Relay Therapeutics Inc. Common Stock vs Ultrapar Participacoes S.A. (New) American Depositary Shares (Each representing one Common Share) — how do they compare? Relay Therapeutics Inc. Common Stock trades at $18.07 (market cap $3.82B), while Ultrapar Participacoes S.A. (New) American Depositary Shares (Each representing one Common Share) trades at $8.01 (market cap $8.29B). The key difference: Ultrapar Participacoes S.A. (New) American Depositary Shares (Each representing one Common Share) is far larger — about 2.2× Relay Therapeutics Inc. Common Stock's market cap, and Ultrapar Participacoes S.A. (New) American Depositary Shares (Each representing one Common Share) pays a 4.82% dividend while Relay Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Relay Therapeutics Inc. Common Stock for 0 Days and Ultrapar Participacoes S.A. (New) American Depositary Shares (Each representing one Common Share) for 0 Days on average.
| RLAY | UGP | |
|---|---|---|
Market Cap | $3.82B | $8.29B |
Volume | 4,332,079 | 4,931,275 |
Sector | Health | Energy |
52-Week High | $20.75 | $7.79 |
52-Week Low | $6.03 | $3.63 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $2.93B | $10.34B |
Dividend Yield | — | 4.82% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →Ultrapar is a Brazilian company with fuel distribution, liquefied petroleum gas, and chemical businesses. Its consumer-facing operations include fuel and gas distribution brands.
Read more on UGP →